Preventing Opportunistic Infections in HIV-Infected Injection Drug Users

JAMA: The Journal of the American Medical Association

Volumn 278, Issue 21, 1997, Pages 1743-

  Perlman, David C ^a   Des Jarlais, Don C ^a   Salomon, Nadim ^a   Masson, Carmen L ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INJECTION; LETTER; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0030685699     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03550210041033     Document Type: Letter

References (5)

1. Centers for Disease Control and Prevention. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1997;46(RR-12):1-48.
2. Kaplan JE, Masur H, Jaffe HW, Holmes KK. Preventing opportunistic infections in persons infected with HIV: 1997 guidelines. JAMA. 1997;278:337-338.
3. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642-654.
4. Centers for Disease Control and Prevention. Update: trends in AIDS incidence—United States, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:861-867.
5. US Dept of Health and Human Services. Medical Advice for Persons Who Inject Illicit Drugs. Bethesda, Md: US Dept of Health and Human Services; May 9, 1997. HIV Prevention Bulletin.